Skip to main content

Healthcare AI in the EU: GDPR and EU AI Act Dual Compliance

Healthcare AI in Europe usually fails when teams treat GDPR and the EU AI Act as separate workstreams. One team focuses on redaction and residency. Another focuses on oversight and transparency. The production route ends up satisfying neither cleanly because data handling and decision handling are being designed in different places. Keeptrusts is useful precisely because it can put both concerns into one runtime control chain: pii-detector, hipaa-phi-detector, data-routing-policy, bias-monitor, human-oversight, quality-scorer, and audit-logger map well to the dual-compliance problem.

Use this page when​

  • You are deploying AI in European hospitals, clinics, diagnostics organizations, or digital health programs.
  • You need to satisfy GDPR Article 9 health-data protection and EU AI Act high-risk oversight requirements together.
  • You want technical controls for residency, review, fairness, and evidence instead of a documentation-only compliance story.

Primary audience​

  • Primary: Technical Leaders
  • Secondary: Technical Engineers, Privacy and clinical governance teams

The problem​

GDPR and the EU AI Act overlap in healthcare but they do not ask exactly the same question. GDPR asks how special-category health data is handled, minimized, and transferred. The EU AI Act asks how a high-risk system is governed, overseen, documented, and monitored. If you only solve one side, you still have a production gap. A route can be EU-resident and still be dangerously under-supervised. It can also have review procedures and still route health data through a provider posture that privacy teams cannot defend.

This is especially visible in clinical-assistant workflows. Hospitals often start with transcription, summarization, or patient communication support, then expand into triage language, recommendations, or workflow prioritization. The route becomes higher risk over time, but the original governance design is rarely updated to match.

The third problem is evidence fragmentation. DPIA teams, DPOs, clinical safety reviewers, and AI governance groups each want a different slice of proof. If the route has no common event trail, the organization spends more time reconciling logs than improving controls.

The solution​

Dual compliance works best when the route is built from two layers that reinforce each other. The GDPR layer uses pii-detector, hipaa-phi-detector, and data-routing-policy to minimize health data and keep it on approved providers. The EU AI Act layer uses bias-monitor, human-oversight, quality-scorer, and audit-logger to create the review, fairness, and evidence posture expected for high-risk healthcare AI.

That model also supports deployment choices. When an organization needs stronger sovereignty or tokenization, Regulated Execution adds residency, tokenization, and signed evidence features around the route. The route then becomes one place where privacy, clinical safety, and AI governance teams can agree on the live boundary.

The source pages to use are Healthcare (EU GDPR), EU AI Act Compliance, Healthcare (HIPAA) for comparative thinking, and the Policy Controls Catalog. The main operating principle is to stop treating privacy and oversight as separate rollout phases.

Implementation​

This route enforces health-data minimization, approved provider routing, fairness review, and mandatory human oversight for high-risk healthcare output.

pack:
  name: eu-healthcare-dual-compliance
  version: 1.0.0
  enabled: true

providers:
  targets:
    - id: mistral-eu-health
      provider: mistral
      model: mistral-large-latest
      secret_key_ref:
        env: MISTRAL_API_KEY

policies:
  chain:
    - prompt-injection
    - rbac
    - pii-detector
    - hipaa-phi-detector
    - data-routing-policy
    - bias-monitor
    - human-oversight
    - quality-scorer
    - audit-logger

policy:
  prompt-injection:
    response:
      action: block
      message: Request blocked due to prompt-injection risk.

  rbac:
    deny_if_missing:
      - X-User-ID
      - X-User-Role

  pii-detector:
    action: redact
    healthcare_mode: true

  hipaa-phi-detector:
    mode: hipaa_18
    action: redact
    safe_harbor_method: true

  data-routing-policy:
    require_zero_data_retention: true
    on_no_compliant_provider: block
    log_provider_selection: true

  bias-monitor:
    protected_characteristics:
      - age
      - disability
      - gender
      - race
    threshold: 0.85
    action: escalate

  human-oversight:
    require_human_for:
      - diagnosis-suggestion
      - treatment-recommendation
      - care-priority-decision
    action: escalate
    confidence_threshold: 0.5

  quality-scorer:
    thresholds:
      min_aggregate: 0.8

  audit-logger:
    immutable: true
    retention_days: 1825

This route gives each control a clear job. Redaction and routing enforce data governance. Bias and oversight enforce high-risk control posture. Quality thresholds reduce the chance that weak output is treated as clinically meaningful. Audit evidence ties the whole route together so the organization can export the relevant slice for a DPIA, a safety review, or an internal AI governance board.

Use Tutorial: Exporting Compliance Evidence to build evidence packs, and Resolve an Escalation to operationalize the outputs that stop for human review. When teams disagree about whether a route is blocked for privacy or oversight reasons, the shared event trail usually resolves the dispute faster than policy debate alone.

Results and impact​

The immediate gain is organizational alignment. Privacy, clinical safety, and platform teams stop maintaining parallel stories about the same route. The system has one live control chain and one evidence trail. That makes audits faster and rollout decisions clearer.

It also reduces redesign work later. When a route evolves from summarization into high-risk clinical support, the necessary controls are already present or easy to tighten. That is a far better posture than trying to retrofit oversight controls after adoption has already spread.

Key takeaways​

  • GDPR and the EU AI Act should be implemented together for healthcare AI, not as separate programs.
  • Use pii-detector, hipaa-phi-detector, and data-routing-policy for health-data handling.
  • Use bias-monitor, human-oversight, and quality-scorer for high-risk system governance.
  • Use audit-logger and export workflows so different governance teams can consume the same evidence.
  • Add Regulated Execution when sovereignty, tokenization, or signed evidence requirements are stricter.

Next steps​